Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Melatonin for Peri-implant Diseases
NCT06816277Completed
- Sponsor
- Complutense University of Madrid
- Start
- Sep 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in peri-implantitis comparing Melatonin with Placebo (2 arms). Primary endpoint: Probing depth at 60 days. Started Sep 2020; status: completed.
02
Drugs
melatonin
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT06816277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06816277.